Ionis Pharmaceuticals Soars 22% on HC Wainwright Upgrade
Generated by AI AgentAinvest Movers Radar
Tuesday, Apr 15, 2025 4:33 am ET1min read
IONS--
Ionis Pharmaceuticals, Inc. (IONS) surged 22% in pre-market trading on April 15, 2025, marking a significant rise in its stock price.
Ionis Pharmaceuticals has recently received a boost from HC Wainwright, which upgraded the stock to "Strong Buy" with a price target of $45.00. This price objective suggests a potential upside of 57.23% from the current stock price, reflecting the brokerage's confidence in the company's future performance.
This positive outlook from HC Wainwright is likely to have contributed to the recent surge in Ionis Pharmaceuticals' stock price, as investors respond to the upgraded rating and the potential for significant gains.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet